Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 4/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | MAOB | P27338 | 3/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | MMP1 | P03956 | 7/20 | 0.34 |
| ▸ | POLB | P06746 | 2/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | ADAM17 | P78536 | 2/20 | 0.33 |
| ▸ | MMP13 | P45452 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 2/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1503189 | 1.00 | KMT2A (0.40) | KMT2AALDH1A1MAPK1GAAMAOB | |
| SCHEMBL22719912 | 0.90 | KMT2A (0.39) | KMT2AALDH1A1MAPK1GAAMAOB | |
| SCHEMBL22719950 | 0.89 | MAOB (0.39) | KMT2AALDH1A1MAPK1MAOBMAPT | |
| SCHEMBL22719947 | 0.87 | LMNA (0.46) | KMT2AALDH1A1MAPK1GAAGABRA5 | |
| SCHEMBL1503147 | 0.87 | ALDH1A1 (0.39) | KMT2AALDH1A1MAPK1MAOB | |
| SCHEMBL2147314 | 0.87 | ALDH1A1 (0.41) | KMT2AALDH1A1MAPK1MAOBPOLB | |
| SCHEMBL1503192 | 0.86 | ALDH1A1 (0.40) | KMT2AALDH1A1MAPK1GAAMAOB | |
| SCHEMBL22283910 | 0.83 | ALDH1A1 (0.59) | KMT2AALDH1A1MAPK1GAAMAOB | |
| SCHEMBL12398991 | 0.82 | KMT2A (0.48) | KMT2AALDH1A1MAPK1MAOBPOLB | |
| SCHEMBL1503248 | 0.82 | ALDH1A1 (0.39) | KMT2AALDH1A1MAPK1MAOBL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3687538-B1 | METHODS OF TREATING ELEVATED PLASMA CHOLESTEROL | MONTREAL HEART INST (CA) | 2024-04-17 | — | — | EP | disclosed |
| US-11931348-B2 | Methods of treating elevated plasma cholesterol | Montréal Heart Institute (CA) | 2024-03-19 | — | — | US | disclosed |
| US-20230088095-A1 | METHODS OF TREATING ELEVATED PLASMA CHOLESTEROL | Montréal Heart Institute (CA) | 2023-03-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11931348-B2 | Methods of treating elevated plasma cholesterol | CETP, LDLR, APOB | KMT2A 4239/4885ALDH1A1 568/4885MAPK1 2839/4885 |
| US-20230088095-A1 | METHODS OF TREATING ELEVATED PLASMA CHOLESTEROL | CETP, LDLR, APOB | KMT2A 4239/4885ALDH1A1 568/4885MAPK1 2839/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.